Navigation Links
New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursing Homes
Date:9/24/2007

Findings Raise Serious Concerns for Massive, Pending Carlyle Group Takeover

of HCR Manor Care

SEIU Calls on Carlyle to Ensure Buyout Doesn't Worsen Care

WASHINGTON, Sept. 24 /PRNewswire-USNewswire/ -- A stunning front page expose by the New York Times Sunday details how cuts to staffing and operations at nursing homes bought by private equity firms across the country have enriched top executives and buyout firms but left residents worse off. The newspaper's investigation raises serious concerns as huge buyout firm the Carlyle Group finalizes this fall what will be the largest-ever takeover of a nursing home chain, the $6.3 billion buyout of HCR Manor Care.

Last week, the nation's largest healthcare workers union, SEIU, launched a nationwide effort calling on Carlyle to put patient care above CEO profits in the Manor Care takeover. For more visit http://www.CarlyleFixManorCareNow.org

The New York Times' investigation found:

-- Serious Quality of Care Deficiencies -- "Serious quality-of-care deficiencies -- like moldy food and the restraining of residents for long periods or the administration of wrong medications -- rose at every large nursing home chain after it was acquired by a private investment group from 2000 to 2006, even as citations declined at many other homes and chains."

-- -- Staffing Cuts, Sometimes Below Legal Levels -- "At 60 percent of homes bought by large private equity groups from 2000 to 2006, managers have cut the number of clinical registered nurses, sometimes far below levels required by law. During that period, staffing at many of the nation's other homes has fallen much less or grown."

-- Byzantine Structures To Avoid Responsibility, Regulation -- "Private investment companies have made it very difficult for plaintiffs to succeed in court and for regulators to levy chainwide fines by creating com
'/>"/>

SOURCE SEIU
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. No harm in reducing prenatal check up to 3 - 6 times says WHO report
2. Smoking Increases The Risk Of Heart Disease By Three Times
3. Mobile Operating Theater to Cut Waiting Times
4. 37 times unlucky – Failure to Diagnose Cancer, Takes the Life of a 31 year old fathe
5. Health Minister Promises New Benchmark for Wait Times
6. Innovative solution to help reduce the waiting times for kidney transplants
7. Kidney Failure three times pronounced with obesity
8. Long Patient Waiting Times Force NHS Patients To Seek Treatment Abroad
9. Take it if you can - Tough Times in Life Churn out Greenhorns
10. Its all in the mind and the eyes: senses deceive sometimes!
11. Kenyan Women Six Times More Likely To Be HIV Positive Than Kenyan Men
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Within3 Expands into Mobile Applications 2Congressman Fattah Supports Legislation to Address More Funds for Pancreatic Cancer Research 60857 1Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th 14754 1Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th 14754 2Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th 14754 3Caraco Pharmaceutical Laboratories Ltd Markets Generic Acular 28R 29 Ophthalmic Solution 6058 1Caraco Pharmaceutical Laboratories Ltd Markets Generic Acular 28R 29 Ophthalmic Solution 6058 2